The Nilachal Carbo Metalicks IPO is a closed SME Fixed Price offer (Fresh Capital-cum-Offer for Sale) that opened on 8 September 2025. The Nilachal Carbo Metalicks IPO closed on 11 September 2025, with an issue price of ₹85 per share. The Nilachal Carbo Metalicks IPO has a face value of ₹10 and a lot size of 1,600 shares. The Nilachal Carbo Metalicks IPO is listed on 16 September 2025. The Nilachal Carbo Metalicks IPO allotment was scheduled for 12 September 2025.
On the financial front, the Nilachal Carbo Metalicks IPO reported revenue of ₹203 crore for 31 Mar 2025, compared with ₹267 crore for 31 Mar 2024. The Nilachal Carbo Metalicks IPO PAT was ₹14 crore against ₹16 crore. The Nilachal Carbo Metalicks IPO EBITDA stood at ₹27 crore with a 13.46% margin. The Nilachal Carbo Metalicks IPO net worth as of 31 Mar 2025 was ₹78 crore.
Always verify The Nilachal Carbo Metalicks IPO details and GMP data with the official offer document before investing in the Nilachal Carbo Metalicks IPO.
Financial Summary
Amount in Crore
Metric
31 Mar 2025
31 Mar 2024
31 Mar 2023
Total Assets
123
114
93
Revenue
203
267
268
PAT
14
16
15
EBITDA
27
22
25
Net Worth
78
64
48
Reserves
56
42
26
Total Borrowing
24
26
19
Nilachal Carbo Metalicks IPO Financials FAQs
Revenue of Nilachal Carbo Metalicks (Amount in Crore) — 31 Mar 2025: 203; 31 Mar 2024: 267; 31 Mar 2023: 268. Profit after tax (PAT) — 31 Mar 2025: 14; 31 Mar 2024: 16; 31 Mar 2023: 15.
EBITDA of Nilachal Carbo Metalicks (Amount in Crore) — 31 Mar 2025: 27; 31 Mar 2024: 22; 31 Mar 2023: 25. The EBITDA margin is 13.46%.
Total assets — 31 Mar 2025: 123; 31 Mar 2024: 114; 31 Mar 2023: 93. Net worth — 31 Mar 2025: 78; 31 Mar 2024: 64; 31 Mar 2023: 48. Reserves & surplus — 31 Mar 2025: 56; 31 Mar 2024: 42; 31 Mar 2023: 26. (Amount in Crore)
Total borrowing of Nilachal Carbo Metalicks (Amount in Crore) — 31 Mar 2025: 24; 31 Mar 2024: 26; 31 Mar 2023: 19. Debt-to-equity ratio: 0.30.
The financials shown for Nilachal Carbo Metalicks IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
